1. Home
  2. MXCT vs RFI Comparison

MXCT vs RFI Comparison

Compare MXCT & RFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • RFI
  • Stock Information
  • Founded
  • MXCT 1999
  • RFI 1992
  • Country
  • MXCT United States
  • RFI United States
  • Employees
  • MXCT N/A
  • RFI N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RFI Investment Managers
  • Sector
  • MXCT Health Care
  • RFI Finance
  • Exchange
  • MXCT Nasdaq
  • RFI Nasdaq
  • Market Cap
  • MXCT 275.7M
  • RFI 312.2M
  • IPO Year
  • MXCT 2021
  • RFI N/A
  • Fundamental
  • Price
  • MXCT $2.21
  • RFI $12.04
  • Analyst Decision
  • MXCT Strong Buy
  • RFI
  • Analyst Count
  • MXCT 1
  • RFI 0
  • Target Price
  • MXCT $9.00
  • RFI N/A
  • AVG Volume (30 Days)
  • MXCT 811.6K
  • RFI 69.8K
  • Earning Date
  • MXCT 05-07-2025
  • RFI 01-01-0001
  • Dividend Yield
  • MXCT N/A
  • RFI 8.25%
  • EPS Growth
  • MXCT N/A
  • RFI N/A
  • EPS
  • MXCT N/A
  • RFI N/A
  • Revenue
  • MXCT $37,675,000.00
  • RFI N/A
  • Revenue This Year
  • MXCT $9.05
  • RFI N/A
  • Revenue Next Year
  • MXCT $19.98
  • RFI N/A
  • P/E Ratio
  • MXCT N/A
  • RFI N/A
  • Revenue Growth
  • MXCT N/A
  • RFI N/A
  • 52 Week Low
  • MXCT $2.21
  • RFI $9.62
  • 52 Week High
  • MXCT $5.26
  • RFI $12.52
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 31.54
  • RFI 55.42
  • Support Level
  • MXCT $2.60
  • RFI $11.94
  • Resistance Level
  • MXCT $2.86
  • RFI $12.24
  • Average True Range (ATR)
  • MXCT 0.15
  • RFI 0.16
  • MACD
  • MXCT -0.03
  • RFI 0.04
  • Stochastic Oscillator
  • MXCT 5.43
  • RFI 70.59

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About RFI Cohen & Steers Total Return Realty Fund Inc.

Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.

Share on Social Networks: